Posts Tagged ‘alemtuzumab’

June 14, 2011

Alemtuzumab induction in renal transplantation


Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

Alemtuzumab is a monoclonal antibody developed for treatment of lymphoma that profoundly depletes both T- and B-cells, and has been used off-label in transplantation. This randomized controlled trial compared alemtuzumab to induction with either thymoglobulin or basiliximab, and with rapid corticosteroid withdrawal. There were fewer acute rejections at one year with alemtuzumab compared to conventional […]

No Comments Posted in Renal Transplantation